Bellevue Life Sciences Acquisition
BLAC | NASDAQ
$3.01
-$3.72 (-55.27%)
At close: Feb 14, 2025, 04:00 PM ET
-55.27%
(1D)Rating
Key Statistics
Market Data
Market Cap $6.98M
1D Range
3.01 4.43
52W Range
3.01 13.40
Valuation (TTM)
PE 0.84
PB 0.06
EV/EBITDA -0.64
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target N/A
Cash Flow
FCF Yield -41.2%
SBC Adj. FCF Yield -41.2%
SBC Impact N/A
Margins
Gross Margin 35.3%
Operating Margin -933.8%
FCF Margin -159.0%
Growth (CAGR)
Revenue 3Y | 5Y 73.2% |
74.4%
Dil EPS 3Y | 5Y 355.5% |
237.9%
FCF 3Y | 5Y -26.7% |
-36.2%
Returns
ROA 7.3%
ROE 12.6%
ROIC -10.6%
Financial Health
Net Cash
$921.42K
Current Ratio 0.18
Interest Coverage 173.66
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Bellevue Life Sciences Acquisition Corp. currently does not engage in substantial operational activities. Its core mission is to orchestrate a business combination, which could manifest as a merger, s...
Sector Financial Services
Industry Shell Companies
Employees n/a
IPO Date Mar 21, 2023
Website www.bellevuespac.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BLAC